Fernandez-Ramirez Maria Del Carmen, Nguyen Binh A, Singh Virender, Afrin Shumaila, Evers Bret, Basset Parker, Wang Lanie, Pękała Maja, Ahmed Yasmin, Singh Preeti, Canepa Jacob, Wosztyl Aleksandra, Li Yang, Saelices Lorena
Center for Alzheimer's and Neurodegenerative Diseases, Department of Biophysics, Peter O'Donnell Jr. Brain Institute, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
Department of Pathology, University of Texas Southwestern Medical Center (UTSW), Dallas, TX, USA.
bioRxiv. 2024 May 14:2024.05.14.594218. doi: 10.1101/2024.05.14.594218.
ATTR amyloidosis is a degenerative disorder characterized by the systemic deposition of the protein transthyretin. These amyloid aggregates of transthyretin (ATTR) can deposit in different parts of the body causing diverse clinical manifestations. Our laboratory aims to investigate a potential relationship between the different genotypes, organ of deposition, clinical phenotypes, and the structure of ATTR fibrils. Using cryo-electron microscopy, we have recently described how the neuropathic related mutations ATTRv-I84S and ATTRv-V122∆ can drive structural polymorphism in fibrils. Here we question whether the mutation ATTRv-T60A, that commonly triggers cardiac and neuropathic symptoms, has a similar effect. To address this question, we extracted and determined the structure of ATTR-T60A fibrils from multiple organs (heart, thyroid, kidney, and liver) from the same patient and from the heart of two additional patients. We have found a consistent conformation among all the fibril structures, acquiring the "closed-gate morphology" previously found in ATTRwt and others ATTRv related to cardiac or mixed manifestations. The closed-gate morphology is composed by two segments of the protein that interact together forming a polar channel, where the residues glycine 57 to isoleucine 68 act as a gate of the polar cavity. Our study indicates that ATTR-T60A fibrils present in peripheral organs adopt the same structural conformation in all patients, regardless of the organ of deposition.
转甲状腺素蛋白淀粉样变性是一种退行性疾病,其特征是转甲状腺素蛋白在全身沉积。这些转甲状腺素蛋白(ATTR)淀粉样聚集体可沉积在身体不同部位,导致多种临床表现。我们实验室旨在研究不同基因型、沉积器官、临床表型与ATTR纤维结构之间的潜在关系。利用冷冻电子显微镜,我们最近描述了与神经病变相关的突变ATTRv-I84S和ATTRv-V122∆如何驱动纤维中的结构多态性。在这里,我们质疑通常引发心脏和神经病变症状的突变ATTRv-T60A是否有类似作用。为解决这个问题,我们从同一患者的多个器官(心脏、甲状腺、肾脏和肝脏)以及另外两名患者的心脏中提取并确定了ATTR-T60A纤维的结构。我们发现所有纤维结构中存在一致的构象,呈现出先前在ATTRwt以及与心脏或混合表现相关的其他ATTRv中发现的“闭合门形态”。闭合门形态由蛋白质的两个片段组成,它们相互作用形成一个极性通道,其中甘氨酸57至异亮氨酸68的残基充当极性腔的门。我们的研究表明,无论沉积器官如何,外周器官中存在的ATTR-T60A纤维在所有患者中都采用相同的结构构象。